background
differenti
bacteri
viral
pneumonia
import
guid
target
manag
judici
use
antibiot
assess
clinic
characterist
blood
inflammatori
biomark
could
use
distinguish
bacteri
viral
pneumonia
method
western
australian
children
year
hospit
radiologicallyconfirm
communityacquir
pneumonia
recruit
clinic
symptom
manag
data
collect
creactiv
protein
crp
white
cell
count
wcc
absolut
neutrophil
count
anc
measur
part
routin
care
clinic
characterist
biomark
level
compar
case
definit
bacteri
pneumonia
clinic
empyema
andor
bacteria
detect
blood
pleural
fluid
presum
viral
pneumonia
presenc
viru
nasopharyng
swab
without
criteria
definit
bacteri
pneumonia
pneumonia
case
pneumonia
absenc
criteria
either
definit
bacteri
presum
viral
pneumonia
areaundercurv
auc
receiv
oper
characterist
roc
curv
vari
biomark
level
use
characteris
util
discrimin
definit
bacteri
presum
viral
pneumonia
biomark
auc
fair
discrimin
youden
index
measur
determin
optim
cutoff
threshold
sensit
specif
predict
valu
posit
neg
calcul
investig
whether
better
discrimin
could
achiev
combin
biomark
valu
presenceabs
symptom
continu
next
page
global
pneumonia
lead
caus
hospit
death
among
children
nearli
million
new
case
one
million
death
year
australia
pneumonia
associ
hospitalis
per
childyear
among
children
year
old
death
rare
australian
aborigin
children
time
risk
infecti
diseas
nonaborigin
children
respiratori
bacteria
virus
frequent
detect
specimen
collect
children
pneumonia
identifi
infecti
agent
associ
ill
guid
manag
infect
facilit
judici
use
antibiot
differenti
bacteri
viral
pneumonia
base
clinic
characterist
challeng
clinic
sign
symptom
overlap
despit
grow
avail
molecular
techniqu
pathogen
detect
includ
quantit
qualit
pathogen
detect
laboratori
result
usual
avail
treatment
decis
made
sever
studi
assess
util
nonspecif
inflammatori
biomark
creactiv
protein
crp
acutephas
reactant
releas
respons
cytokin
white
cell
count
wcc
absolut
neutrophil
count
anc
discrimin
probabl
bacteri
infect
nonbacteri
infect
also
assess
sever
ill
bacteri
pneumonia
associ
higher
crp
wcc
anc
viral
pneumonia
studi
found
differ
biomark
among
bacteri
viral
case
pneumonia
even
studi
report
differ
biomark
determin
reliabl
threshold
differenti
bacteri
pneumonia
viral
pneumonia
previou
studi
also
affect
small
sampl
size
use
less
sensit
method
pathogen
detect
could
result
inaccur
categor
bacteri
viral
case
furthermor
studi
conduct
lowincom
set
contribut
bacteri
infect
may
higher
children
higher
risk
infecti
diseas
could
influenc
biomark
level
confound
analysi
aetiolog
childhood
pneumonia
chang
highincom
set
routin
pneumococc
conjug
vaccin
programdecreas
bacteri
aetiolog
increas
viral
aetiolog
report
howev
util
inflammatori
biomark
highlyvaccin
paediatr
popul
pneumonia
differenti
bacteri
viral
pneumonia
rare
assess
therefor
assess
distribut
inflammatori
biomark
crp
wcc
anc
blood
sampl
prospect
casecontrol
studi
western
australian
children
radiologicallyconfirm
pneumonia
compar
clinic
characterist
biomark
level
among
pneumonia
case
detect
bacteria
virus
assess
cutoff
threshold
biomark
discrimin
bacteri
pneumonia
viral
pneumonia
find
studi
could
help
develop
rapid
pointofcar
diagnost
tool
algorithm
predict
like
caus
pathogen
assist
clinician
target
manag
childhood
pneumonia
may
octob
prospect
enrol
children
age
year
radiologicallyconfirm
communityacquir
pneumonia
mention
case
hospit
princess
margaret
hospit
children
pmh
perth
australia
known
perth
children
hospit
studi
hospit
publicallyfund
tertiari
paediatr
hospit
total
popul
million
western
australia
follow
pragmat
definit
radiologicallyconfirm
pneumonia
infiltr
alveolar
consolid
determin
treat
clinician
facilit
recruit
hour
ie
radiologist
avail
review
chest
xray
studi
design
elig
criteria
publish
previous
exist
ever
diagnos
comorbid
consid
exclus
criteria
structur
questionnair
administ
parent
guardian
record
demograph
clinic
inform
includ
symptom
clinic
observ
includ
respiratori
rate
oxygen
satur
present
highest
measur
temperatur
need
intraven
fluid
oxygen
supplement
respiratori
support
record
review
medic
note
part
medic
care
blood
specimen
collect
case
treat
clinician
test
creactiv
protein
crp
concentr
white
cell
count
wcc
absolut
neutrophil
count
anc
count
blood
cultur
hospit
laboratori
pleural
fluid
drain
case
pleural
effus
assess
microscopi
cultur
polymeras
chain
reaction
pcr
bacteri
pathogen
nasopharyng
swab
np
floqswab
copan
diagnost
murrieta
ca
collect
follow
standard
sampl
collect
procedur
within
h
present
hospit
present
swab
test
total
respiratori
virus
influenza
b
respiratori
syncyti
viru
rsv
human
parainfluenza
viru
hpiv
type
human
metapneumoviru
hmpv
adenoviru
av
rhinoviru
rv
human
coronaviru
hcov
hcov
hcov
hcov
bacteria
streptococcu
pneumonia
staphylococcu
aureu
moraxella
catarrhali
haemophilu
influenza
mycoplasma
pneumonia
chlamydophila
pneumonia
use
polymeras
chain
reaction
pcr
laboratori
procedur
includ
nucleic
acid
extract
primer
probe
use
pcr
describ
previous
agespecif
tachypnoea
defin
per
world
health
organ
criteria
respiratori
rate
breath
min
children
age
month
breathsmin
children
age
month
breathsmin
children
age
year
diseas
sever
case
assess
respiratori
index
sever
children
risc
score
use
sever
respiratori
sign
physic
examin
hospit
present
follow
child
growth
standard
risc
score
could
rang
higher
score
indic
increas
sever
case
categoris
three
distinct
group
base
probabl
pneumonia
aetiolog
definit
bacteri
case
case
clinic
empyema
least
one
put
bacteri
pathogen
detect
blood
pleural
fluid
cultur
pcr
regardless
detect
respiratori
virus
np
b
presum
viral
case
case
without
empyema
bacteria
detect
blood
pleural
fluid
least
one
respiratori
viru
detect
np
without
bacteria
detect
np
c
pneumonia
case
case
fulfil
neither
criteria
definit
bacteri
presum
viral
without
bacteria
detect
np
frequenc
clinic
characterist
report
group
categor
clinic
characterist
chisquar
fisher
exact
test
whichev
appropri
use
compar
frequenc
group
continu
variabl
mean
rang
report
data
normal
distribut
otherwis
median
interquartil
rang
iqr
report
student
ttest
wilcoxon
ranksum
test
whichev
appropri
use
compar
group
crp
wcc
anc
concentr
areaundercurv
auc
receiveroperatingcharacterist
roc
curv
describ
abil
marker
differenti
definit
bacteri
pneumonia
presum
viral
pneumonia
case
measur
diagnost
perform
biomark
differenti
bacteri
pneumonia
assess
valu
areaundercurv
auc
consid
excel
discrimin
good
fair
poor
nondiscriminatori
sensit
specif
posit
predict
valu
ppv
neg
predict
valu
npv
differ
cutoff
valu
biomark
auc
valu
assess
youden
index
assess
identifi
optimum
cutoff
distinguish
definit
bacteri
presum
viral
pneumonia
presum
viral
plu
pneumonia
case
explor
combin
symptom
biomark
improv
overal
sensit
specif
discrimin
bacteri
viral
pneumonia
statist
analys
conduct
stata
plot
prepar
use
graphpad
prism
total
children
radiolog
confirm
communityacquir
pneumonia
case
enrol
studi
period
male
age
year
median
age
month
iqr
twentyon
case
aborigin
case
receiv
least
dose
pneumococc
conjug
vaccin
demograph
exist
ever
diagnos
comorbid
enrol
children
summar
tabl
median
length
hospit
day
iqr
children
discharg
death
hospit
present
case
blood
oxygen
satur
spo
level
tachypnoea
observ
nearli
half
case
receiv
antibiot
day
prior
hospit
present
three
receiv
antibiot
hospit
stay
twentyfour
case
diagnos
pleural
effus
pleural
fluid
drain
microscop
purul
consist
empyema
case
definit
bacteri
pneumonia
bacteraemia
empyema
bacteraemia
empyema
pleural
fluid
sampl
empyema
case
cultur
pcr
posit
pcr
posit
streptococcu
pneumonia
cultur
methicillinresist
staphylococcu
aureu
methicillinsensit
staphylococcu
aureu
streptococcu
pyogen
sampl
pcr
posit
mycoplasma
pneumonia
least
one
respiratori
viru
detect
np
case
definit
bacteri
pneumonia
remain
case
least
one
viru
detect
nasopharyng
swab
case
includ
codetect
respiratori
bacteria
among
presum
viral
pneumonia
case
rsv
detect
rhinoviru
hmpv
influenza
adenoviru
parainfluenza
viru
detect
nasopharyng
swab
case
pneumonia
includ
detect
respiratori
bacteria
np
distribut
bacteria
detect
np
three
case
group
pneumonia
present
addit
file
tabl
distribut
bacteria
np
three
case
group
similar
among
case
three
group
definit
bacteri
pneumonia
case
presum
viral
pneumonia
case
pneumonia
case
receiv
antibiot
hospit
clinic
featur
case
medic
intervent
summar
tabl
differ
clinic
symptom
sign
observ
across
differ
group
tabl
fever
defin
temperatur
frequent
observ
definit
bacteri
pneumonia
presum
viral
p
pneumonia
case
p
rhinorrhoea
frequent
presum
viral
pneumonia
either
definit
bacteri
pneumonia
p
pneumonia
case
p
agespecif
tachypnoea
also
common
presum
viral
pneumonia
definit
bacteri
p
pneumonia
case
p
definit
bacteri
pneumonia
case
requir
intraven
fluid
therapi
presum
viral
p
pneumonia
case
p
furthermor
half
definit
bacteri
case
requir
supplement
intraven
fluid
substanti
higher
presum
viral
p
pneumonia
case
p
tabl
definit
bacteri
pneumonia
case
also
greater
median
length
hospit
stay
day
day
empyema
day
without
presum
viral
day
pneumonia
day
p
mean
risc
sever
score
rang
definit
bacteri
case
compar
presum
viral
pneumonia
case
respect
median
blood
crp
concentr
time
higher
definit
bacteri
case
presum
viral
versu
mgl
p
pneumonia
case
versu
mgl
p
crp
wcc
anc
vari
significantli
presum
viral
pneumonia
case
empyema
bacteraemia
case
tabl
addit
file
tabl
blood
biomark
valu
vari
significantli
presum
viral
case
differ
viral
pathogen
detect
data
shown
condit
abnorm
b
respiratori
ill
neuromuscular
disord
ill
c
igg
subclass
defici
n
low
iga
n
tcell
defici
n
mannosebind
lectin
defici
n
digeorg
syndrom
n
b
capillari
malfunct
syndrom
n
beckwithwiedemann
syndrom
congenit
hypothoroid
n
atrioventricular
septal
defect
n
syndrom
n
soto
syndrom
n
spinal
muscular
atrophi
type
n
development
delay
n
congenit
heart
diseas
n
prader
willi
syndrom
n
congenit
sensorineur
deaf
n
ehlersdanlo
syndrom
n
gasroschisi
n
cleft
lip
n
c
intracrani
shunt
n
auc
crp
ci
discrimin
definit
bacteri
presum
viral
pneumonia
fig
ci
discrimin
definit
bacteri
presum
viral
plu
pneumonia
fig
wcc
auc
ci
ci
discrimin
definit
bacteri
presum
viral
plu
other
pneumonia
definit
bacteri
presum
viral
pneumonia
respect
addit
file
figur
anc
auc
ci
ci
discrimin
definit
bacteri
presum
viral
plu
pneumonia
definit
bacteri
presum
viral
pneumonia
respect
addit
file
figur
base
auc
assess
sensit
specif
ppv
npv
crp
cutoff
mgl
mgl
mgl
differenti
bacteri
presum
viral
plu
pneumonia
definit
bacteri
presum
viral
pneumonia
addit
file
tabl
crp
mgl
crp
mgl
crp
mgl
cutoff
sensit
respect
differenti
definit
bacteri
pneumonia
presum
viral
pneumonia
youden
index
optim
crp
threshold
mgl
found
discrimin
definit
bacteri
presum
viral
plu
pneumonia
sensit
ci
specif
ci
ppv
npv
discrimin
definit
bacteri
presum
viral
pneumonia
sensit
ci
specif
ci
ppv
npv
tabl
signific
differ
symptom
sign
includ
assess
impact
diagnost
perform
algorithm
tabl
addit
file
tabl
combin
crp
mgl
either
presenc
fever
absenc
rhinorrhea
improv
ppv
combin
crp
mgl
fever
crp
mgl
absenc
rhinorrhea
discrimin
definit
bacteri
presum
viral
plu
pneumonia
respect
discrimin
definit
bacteri
presum
viral
pneumonia
respect
tabl
studi
describ
clinic
characterist
children
radiolog
confirm
pneumonia
assess
util
serum
biomark
clinic
sign
symptom
differenti
definit
bacteri
pneumonia
highli
vaccin
popul
differ
children
definit
bacteri
pneumonia
presum
viral
pneumonia
pneumonia
neither
definit
bacteri
presum
viral
crp
wcc
anc
higher
definit
bacteri
pneumonia
crp
valu
distinguish
presum
viral
pneumonia
combin
high
crp
either
fever
absenc
rhinorrhoea
increas
specif
ppv
compar
elev
crp
alon
littl
loss
sensit
suggest
combin
biomark
clinic
featur
diagnost
valu
time
identif
pneumonia
aetiolog
could
improv
clinic
manag
includ
decis
use
antibiot
line
previou
studi
clinic
sign
symptom
among
case
definit
bacteri
presum
viral
pneumonia
overlap
insuffici
specif
reliabl
differenti
one
find
mostli
consist
previou
studi
associ
viral
pneumonia
low
grade
fever
tachypnoea
rhinorrhoea
wheez
attempt
distinguish
case
base
specif
radiograph
featur
other
found
radiograph
featur
reliabl
distinguish
bacteri
viral
pneumonia
conflict
report
util
serum
inflammatori
biomark
crp
wcc
anc
differenti
bacteri
viral
pneumonia
children
uk
children
elemraid
et
al
found
higher
crp
wcc
anc
bacteri
compar
viral
pneumonia
crp
level
mgl
reportedli
distinguish
sever
bacteri
pneumonia
viral
pneumonia
sensit
specif
crp
mgl
differenti
bacteri
versu
viralatyp
pneumonia
children
communityacquir
pneumonia
respect
norway
respect
finland
found
crp
better
discriminatori
util
auc
wcc
anc
consist
find
similar
set
optimum
crp
threshold
differenti
definit
bacteri
presum
viral
pneumonia
moder
predict
valu
could
limit
use
sole
criterion
antibiot
decisionmak
clinic
set
serum
procalcitonin
routin
use
studi
set
could
assess
valu
distinguish
bacteri
pneumonia
presum
viral
pneumonia
serum
procalcitonin
pct
describ
better
biomark
bacteri
sepsi
crp
found
serum
crp
better
predictor
lobar
consolid
pleural
effus
pct
studi
also
attempt
discrimin
bacteri
viral
pneumonia
case
use
either
blood
biomark
clinic
characterist
radiolog
differ
modest
success
knowledg
howev
combin
inflammatori
biomark
clinic
symptom
rare
explor
found
compar
high
crp
mgl
alon
high
crp
either
fever
absenc
rhinorrhoea
improv
specif
ppv
littl
loss
sensit
therebi
improv
diagnost
accuraci
respiratori
bacteria
often
detect
nasopharynx
healthi
asymptomat
children
rare
detect
normal
steril
site
like
blood
pleural
fluid
furthermor
purul
pleural
effus
gener
consid
bacteri
origin
even
bacteria
detect
respiratori
virus
usual
detect
nasopharynx
children
viral
pneumonia
may
also
detect
healthi
children
absenc
gold
standard
microbiolog
assay
distinguish
bacteri
viral
mix
infect
categoris
case
base
whether
highli
like
bacteri
definit
like
viral
presum
possibl
either
base
whether
bacteria
detect
steril
site
respiratori
virus
detect
nasopharynx
neither
pragmat
approach
classif
reflect
limit
current
method
misclassif
like
occur
previou
studi
categoris
case
either
bacteri
viral
limit
due
lower
pathogen
detect
rate
use
less
sensit
assay
strength
studi
rang
pathogen
test
cover
virtual
import
bacteria
virus
associ
childhood
pneumonia
use
sensit
molecular
techniqu
studi
limit
clear
differ
definit
bacteri
presum
viral
pneumonia
case
like
number
latter
group
also
bacteri
pneumonia
mix
infect
note
mani
detect
respiratori
bacteria
nasopharyng
swab
blood
pleural
fluid
note
differ
presum
viral
pneumonia
pneumonia
case
latter
less
like
rhinorrhoea
tachypnoea
suggest
may
compris
higher
proport
bacteri
infect
presum
viral
group
half
case
prior
exposur
antibiot
enrol
might
impact
natur
progress
sign
symptom
biomark
sensit
bacteri
cultur
sputum
sampl
often
use
diagnosi
communityacquir
pneumonia
adult
collect
sputum
children
challeng
studi
found
limit
util
sputum
diagnost
tool
pneumonia
empir
use
antibiot
remain
cornerston
treat
pneumonia
absenc
effect
pointofcar
diagnost
differenti
bacteri
viral
infect
mani
children
viral
pneumonia
continu
receiv
antibiot
without
benefit
earli
reliabl
detect
viral
pneumonia
earli
exclus
bacteri
pneumonia
could
reduc
unnecessari
antibiot
therapi
therebi
mitig
risk
emerg
antibiot
resist
unabl
identifi
singl
biomark
clinic
featur
could
use
confid
distinguish
bacteri
viral
pneumonia
find
suggest
may
util
sophist
algorithm
integr
number
clinic
microbiolog
inflammatori
biomark
radiolog
factor
improv
pneumonia
diagnost
better
target
therapi
addit
file
tabl
show
distribut
four
common
respiratori
bacteria
detect
pcr
nasopharyng
swab
children
definit
bacteri
pneumonia
presum
viral
pneumonia
pneumonia
tabl
inform
reader
bacteria
upper
respiratori
tract
nasopharynx
vari
pneumonia
case
detect
bacteria
steril
bodi
fluid
blood
andor
pleural
fluid
compar
detect
bacteria
steril
bodi
fluid
detect
respiratori
virus
nasopharynx
either
tabl
show
distribut
three
blood
biomark
crp
wcc
anc
among
definit
bacteri
pneumonia
case
empyema
bacteraemia
empyema
bacteraemia
found
definit
bacteri
case
increas
level
blood
biomark
presum
viral
pneumonia
pneumonia
case
tabl
analys
within
definit
bacteri
case
group
see
blood
biomark
vari
among
complic
pneumonia
case
empyema
case
bacteraemia
presenc
bacteria
blood
case
empyema
bacteraemia
tabl
show
differ
diagnost
valu
sensit
specif
posit
predict
valu
ppv
neg
predict
valu
npv
differ
cutoff
valu
crp
level
differenti
definit
bacteri
pneumonia
presum
viral
presum
viral
plu
pneumonia
crp
found
capac
distinguish
definit
bacteri
pneumonia
presum
viral
pneumonia
found
crp
level
mgl
optim
cutoff
point
tabl
assess
diagnost
valu
differ
crp
level
alon
also
presenceabs
clinic
symptom
understand
discriminatori
analysi
definit
bacteri
pneumonia
viral
pneumonia
docx
kb
addit
file
figur
roc
curv
blood
wcc
concentr
differenti
definit
bacteri
pneumonia
presum
viral
pneumonia
radiolog
confirm
cap
case
figur
b
roc
curv
blood
wcc
concentr
differenti
definit
bacteri
pneumonia
presum
viral
plu
pneumonia
radiolog
confirm
cap
case
figur
show
output
discriminatori
analysi
use
roc
curv
blood
wcc
level
figur
show
roc
curv
blood
wcc
distinct
definit
bacteri
pneumonia
presum
viral
pneumonia
areaundercurv
insert
figur
figur
show
roc
curv
blood
wcc
distinct
definit
bacteri
pneumonia
presum
viral
pneumonia
plu
pneumonia
areaundercurv
insert
figur
figur
roc
curv
blood
anc
concentr
differenti
definit
bacteri
pneumonia
presum
viral
pneumonia
radiolog
confirm
cap
case
figur
b
roc
curv
blood
anc
concentr
differenti
definit
bacteri
pneumonia
presum
viral
plu
pneumonia
radiolog
confirm
cap
case
figur
show
output
discriminatori
analysi
use
roc
curv
blood
anc
level
figur
show
roc
curv
blood
anc
distinct
definit
bacteri
pneumonia
presum
viral
pneumonia
areaundercurv
insert
figur
figur
show
roc
curv
blood
anc
distinct
definit
bacteri
pneumonia
presum
viral
pneumonia
plu
pneumonia
avail
data
materi
data
gener
analysi
studi
includ
manuscript
supplementari
inform
file
avail
correspond
author
reason
request
author
contribut
mub
particip
enrol
data
collect
specimen
collect
data
analysi
first
draft
manuscript
subsequ
version
ccb
conceiv
studi
supervis
data
collect
interpret
laboratori
analysi
interpret
clinic
find
supervis
data
analysi
critic
review
manuscript
rw
particip
enrol
data
collect
specimen
collect
critic
review
manuscript
jl
laboratori
test
critic
review
manuscript
tr
laboratori
test
critic
review
manuscript
cg
laboratori
test
critic
review
manuscript
cg
laboratori
test
critic
review
manuscript
mlb
conceiv
studi
support
data
collect
critic
review
manuscript
rbt
supervis
laboratori
test
interpret
laboratori
find
critic
review
manuscript
lsk
supervis
laboratori
test
interpret
laboratori
find
critic
review
manuscript
conceiv
studi
support
data
collect
critic
review
manuscript
pcr
conceiv
studi
critic
review
manuscript
dw
conceiv
studi
supervis
laboratori
test
interpret
laboratori
find
critic
review
manuscript
aj
conceiv
studi
critic
review
manuscript
tl
conceiv
studi
supervis
data
collect
supervis
data
analysi
interpret
clinic
find
critic
review
manuscript
author
read
approv
final
manuscript
ethic
approv
consent
particip
written
inform
consent
obtain
particip
specimen
collect
parentguardian
case
assent
obtain
case
age
year
studi
protocol
approv
human
research
ethic
committe
princess
margaret
hospit
children
pmh
hrec
ref
manuscript
contain
identifi
individu
person
detail
prof
richmond
receiv
grant
glaxosmithklin
novavax
medimmun
janssen
outsid
submit
work
dr
kirkham
patent
licens
pfizer
author
potenti
conflict
interest
declar
